Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment

Author： Messinis I.E.   Loutradis D.   Domali E.   Kotsovassilis C.P.   Papastergiopoulou L.   Kallitsaris A.   Drakakis P.   Dafopoulos K.   Milingos S.  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.20, Iss.11, 2005-11, pp. : 3192-3197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?

By Kyrou D.   Popovic-Todorovic B.   Fatemi H.M.   Bourgain C.   Haentjens P.   Van Landuyt L.   Devroey P.  

Human Reproduction, Vol. 24, Iss. 11, 2009-11 ,pp. : 2902-2909

Oxford University Press

Access to resources Recommend Favorite

Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial*Dr Olivennes and Dr Leader presented data from the study at ESHRE, Berlin, 2004 and ASRM, Philadelphia, 2004.

By Lambalk C.B.   Leader A.   Olivennes F.   Fluker M.R.   Andersen A. Nyboe   Ingerslev J.   Khalaf Y.   Avril C.   Belaisch-Allart J.   Roulier R.   Mannaerts B.  

Human Reproduction, Vol. 21, Iss. 3, 2006-03 ,pp. : 632-639

Oxford University Press

Access to resources Recommend Favorite

Prognostic value of serum progesterone and LH values on the day of hCG administration in IUI GnRH antagonist cycles

By Matorras R.   Soler A. Valls i   Ramon O.   Burgos J.   Abanto E.   González M.   Múgica J.   Corcóstegui B.   Pijoan J.I.   Exposito Antonia  

Gynecological Endocrinology, Vol. 28, Iss. 3, 2012-03 ,pp. : 157-161

Informa Healthcare

Access to resources Recommend Favorite

Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone ((GnRH)) agonist and GnRH antagonist during cancer treatment in young females

By Potolog-Nahari Claris   Fishman Ami   Cohen Ilan  

Gynecological Endocrinology, Vol. 23, Iss. 5, 2007-11 ,pp. : 290-294

Informa Healthcare

Access to resources Recommend Favorite

In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression

By Van Vaerenbergh Inge   Van Lommel Leentje   Ghislain Vanessa   In't Veld Peter   Schuit Frans   Fatemi Human Mousavi   Devroey Paul   Bourgain Claire  

Human Reproduction, Vol. 24, Iss. 5, 2009-05 ,pp. : 1085-1091

Oxford University Press

Access to resources Recommend Favorite